Adventrx Pharmaceuticals Inc, SynthRx Inc. deal

Adventrx completed its previously announced acquisition of SynthRx in a stock deal valued at up to $37.8 million based on Adventrx's close of $2.32 on April 7, before the deal closed. SynthRx sharehol...